Search results
A conversation with Jie He, M.D. & Ph.D., Director, National Cancer Center; President, Cancer Hospital, Chinese Academy of Medical Sciences
He. W. Guo, …, J. He. Neoadjuvant immunotherapy has brought new hope for patients with non-small cell lung cancer (NSCLC). However, limited by the lack of clinically feasible markers, it is still difficult to select NSCLC patients who respond well and to predict patients’ clinical outcomes before the treatment.
Jie He. Objective: To analyze the incidence and mortality rates of esophagus cancer in China from 2008 to 2012. Methods: Incident and mortality cases of esophagus cancer were retrieved from the ...
May 10, 2023 · The International Agency for Research on Cancer (IARC) and the National Cancer Center of China (NCC China) are setting up an IARC-NCC China Learning Centre to train researchers and practitioners and to foster collaborative cancer prevention research and activities across China and the region. The related Memorandum of Understanding was signed ...
Aug 24, 2019 · Professor Jie He, CPC member, was born in Aug. 1960 in Changchun City, Jilin Province, having his native place inShenyang, Liaoning. He graduated from Norman Bethune Medical University in 1984 and won Doctor’s Degree from PUMC in 1993. He’s now Head of National Cancer Center, President and Secretary of CPC Committee of CAMS Cancer Hospital ...
Aug 1, 2022 · Jie He. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Search for more papers by this author
Oncogene 36 (42), 5874-5884. , 2017. 85. 2017. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota. HL Huang, HT Chen, QL Luo, HM Xu, J He, YQ Li, YL Zhou, F Yao, ... Journal of digestive diseases 20 (8), 401-408.
